Prof. Charlotte Beaudart to receive Scientific Award from the AstraZeneca Foundation

Every year, the AstraZeneca Foundation awards three scientific prizes to researchers in the intermediate stage of their career and who have carried out important contributions in a specific domain. Topics are renewed for each edition. The FNRS and the FWO are in charge of collecting the applications and selecting experts to designate the three laureates.

In 2023, one of the three highlighted disciplines is “Healthy Aging from Physiological to Psychological and Ethical Aspects“. And it's in this category that Prof. Charlotte Beaudart has been designated as the winner!

The AstraZeneca Foundation awards ceremony will take place on the 13th of December 2023 at the Palace of the Academies in Brussels. As a laureate, Charlotte Beaudart will receive a prize of 25.000 € to continue making valuable contributions towards healthy aging.

Over 11 years of dedicated research in the field of aging

Charlotte Beaudart holds a PhD in Public Health Sciences, Epidemiology, and Health Economics from the ULiège. In September 2023, she joined the Biomedical Sciences Department of UNamur as Professor in Clinical Research.

For more than 11 years, her research efforts were dedicated to exploring different facets of aging, first during her doctoral studies from 2012 to 2016, and subsequently as a postdoctoral researcher and mentor of PhD candidates from 2016 to 2023. She specifically focused her research on understanding the aging process and its association with osteoarticular and musculoskeletal pathologies. She has been actively involved in studying sarcopenia, osteoporosis, osteoarthritis, as well as intrinsic capacities and malnutritionin the elderly. One of her groundbreaking endeavors is the creation of the SarcoPhAge cohort—involving over 500 patients aged over 60 from Liège. This prospective cohort study has spanned nearly a decade, providing invaluable insights into the dynamics of aging. Charlotte is also renowned for developing the SarQoL, the world's first quality of life questionnaire tailored specifically for sarcopenia. She has furthermore been actively involved in conducting patients’ preference studies. Overall, her work aims at placing patients at the center of their care and empowering individuals to become active participants in their own health journeys.